ERBB2 and breast cancer: Moreover, univariate analysis of OS and DFS revealed that HOTTIP overexpression was an unfavorable prognostic factor in BC patients (OS, P=0.002; DFS, P<0.001; Table 3, 4), regardless of other clinicopathological features, such as tumor size, lymph node metastasis, TNM stage, Her-2 status.